Literature DB >> 59039

Letter: Interferon treatment of dendritic keratitis.

R Sundmacher, D Neumann-Haefelin, K Cantell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 59039     DOI: 10.1016/s0140-6736(76)93052-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

Review 2.  Clinical uses of interferons.

Authors:  Robert M Friedman
Journal:  Br J Clin Pharmacol       Date:  2007-12-07       Impact factor: 4.335

Review 3.  Human MX2/MxB: a Potent Interferon-Induced Postentry Inhibitor of Herpesviruses and HIV-1.

Authors:  Peter Staeheli; Otto Haller
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

4.  The treatment of herpes simplex virus epithelial keratitis.

Authors:  K R Wilhelmus
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 5.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2010-12-08

6.  Intramuscular and/or intralumbar postexposure treatment of rabies virus-infected cynomolgus monkeys with human interferon.

Authors:  E Weinmann; M Majer; J Hilfenhaus
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Treatment of hepatitis C infections with interferon: a historical perspective.

Authors:  Robert M Friedman; Sara Contente
Journal:  Hepat Res Treat       Date:  2010-09-06

8.  Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model.

Authors:  D Neumann-Haefelin; R Sundmacher; R Skoda; K Cantell
Journal:  Infect Immun       Date:  1977-08       Impact factor: 3.441

Review 9.  Interferons as Therapy for Viral and Neoplastic Diseases: From Panacea to Pariah to Paragon.

Authors:  Robert M Friedman; Sara Contente
Journal:  Pharmaceuticals (Basel)       Date:  2009-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.